These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15516796)

  • 1. PCR method for genotyping and zygosity-testing of RasH2 transgenic mice.
    Suemizu H; Kito-Maruyama C; Sotomaru Y; Ogura T; Hioki K; Ohnishi Y; Tamaoki N
    Exp Anim; 2004 Oct; 53(5):463-6. PubMed ID: 15516796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tg rasH2 mouse in cancer hazard identification.
    Morton D; Alden CL; Roth AJ; Usui T
    Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice.
    Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y
    Carcinogenesis; 1996 Nov; 17(11):2455-61. PubMed ID: 8968063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice.
    Takaoka M; Sehata S; Maejima T; Imai T; Torii M; Satoh H; Toyosawa K; Tanakamaru ZY; Adachi T; Hisada S; Ueda M; Ogasawara H; Matsumoto M; Kobayashi K; Mutai M; Usui T
    Toxicol Pathol; 2003; 31(2):191-9. PubMed ID: 12696579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of palindromic symmetry in Tg.AC mice with a nonresponder phenotype.
    Honchel R; Rosenzweig BA; Thompson KL; Blanchard KT; Furst SM; Stoll RE; Sistare FD
    Mol Carcinog; 2001 Feb; 30(2):99-110. PubMed ID: 11241757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing.
    Suemizu H; Muguruma K; Maruyama C; Tomisawa M; Kimura M; Hioki K; Shimozawa N; Ohnishi Y; Tamaoki N; Nomura T
    Mol Carcinog; 2002 May; 34(1):1-9. PubMed ID: 12112317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of IC tags in short-term carcinogenicity study on CB6F1 TGrasH2 mice.
    Urano K; Suzuki S; Machida K; Sawa N; Eguchi N; Kikuchi K; Fukasawa K; Taguchi F; Usui T
    J Toxicol Sci; 2006 Dec; 31(5):407-18. PubMed ID: 17202757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-six week carcinogenicity study of ampicillin in CB6F1-TgrasH2 mice.
    Adachi T; Kuwamura Y; Fujiwara T; Tanimoto N; Nishimura T; Koguchi A; Kobayashi K; Sasaki Y; Yamaguchi C; Honda T; Kawashima K; Yuasa H; Yamamura T; Inui T
    J Toxicol Sci; 2002 Aug; 27(3):147-63. PubMed ID: 12238139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.
    Yamamoto S; Urano K; Koizumi H; Wakana S; Hioki K; Mitsumori K; Kurokawa Y; Hayashi Y; Nomura T
    Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):57-69. PubMed ID: 9539005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Tumor Induction by 26-week Dermal Application of 1,2-Dichloroethane in CB6F1-Tg rasH2 Mice.
    Suguro M; Numano T; Kawabe M; Doi Y; Imai N; Mera Y; Tamano S
    Toxicol Pathol; 2017 Apr; 45(3):427-434. PubMed ID: 28421967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and precise genotyping of transgene zygosity in mice using an allele-specific method.
    Yang J; DeVore AN; Fu DA; Spicer MM; Guo M; Thompson SG; Ahlers-Dannen KE; Polato F; Nussenzweig A; Fisher RA
    Life Sci Alliance; 2023 Jun; 6(6):. PubMed ID: 37037594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies.
    Mitsumori K; Koizumi H; Nomura T; Yamamoto S
    Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis.
    Tamaoki N
    Toxicol Pathol; 2001; 29 Suppl():81-9. PubMed ID: 11695564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness.
    Thompson KL; Rosenzweig BA; Sistare FD
    Toxicol Pathol; 1998; 26(4):548-55. PubMed ID: 9715514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple method of zygosity identification in transgenic mice by real-time quantitative PCR.
    Shitara H; Sato A; Hayashi J; Mizushima N; Yonekawa H; Taya C
    Transgenic Res; 2004 Apr; 13(2):191-4. PubMed ID: 15198206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-six-Week carcinogenicity study of chloroform in CB6F1 rasH2-transgenic mice.
    Sehata S; Maejima T; Watanabe M; Ogata S; Makino T; Tanaka K; Manabe S; Takaoka M
    Toxicol Pathol; 2002; 30(3):328-38. PubMed ID: 12051550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rasH2 mouse: reproducibility and stability of carcinogenicity due to a standardized production and monitoring system.
    Tsutsumi H; Inoue R; Yasuda M; Takahashi R; Suzuki M; Urano K
    J Toxicol Pathol; 2022 Jan; 35(1):19-24. PubMed ID: 35221492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal mapping and zygosity check of transgenes based on flanking genome sequences determined by genomic walking.
    Noguchi A; Takekawa N; Einarsdottir T; Koura M; Noguchi Y; Takano K; Yamamoto Y; Matsuda J; Suzuki O
    Exp Anim; 2004 Apr; 53(2):103-11. PubMed ID: 15153672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration site analysis in transgenic mice by thermal asymmetric interlaced (TAIL)-PCR: segregating multiple-integrant founder lines and determining zygosity.
    Pillai MM; Venkataraman GM; Kosak S; Torok-Storb B
    Transgenic Res; 2008 Aug; 17(4):749-54. PubMed ID: 18085422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenicity Evaluation of Baclofen in TgrasH2 Mice.
    Chevalier G; Aubert N; Thirion-Delalande C; Palate B; Singh P
    Toxicol Pathol; 2022 Jan; 50(1):153-157. PubMed ID: 34814786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.